Pioneering work in cancer detection

Cell based biomarkers

Founded in 2009, XZELL has leveraged Single Cell PathologyTM to become the leader in early, pain-free cancer detection.

We are dedicated to develop our technologies to detect all cancers possible, as early as possible. This is reflected in our growing number of clinical study sites currently covering prostate, endometrial, ovarian, breast, colorectal and bile duct cancer, as well as in our continuously growing patent portfolio.

Our Team

THE BEST AND BRIGHTEST

Founder

Sebastian Chakrit Punyaratabandhu Bhakdi

Doctor

Staff Members

Joseph Masterson

Operations, MSc

Ponpan Thaicharoen

hMX Cell Separation, MSc

Noppawan Woramongkolchai

Cryoimmunostaining, MSc

Pakawat Kraisintu

Quality Management, MSc

Pataraporn Singhaphet

Engineering, BSE

Advisors

Prida Malasit

MD PhD

Prapat Suriyaphol

PhD

Johannes Hille

Dipl. IBS

Vichit Suraphongchai

MBA

Sucharit Bhakdi

MD

Karina Reiss

PhD

Heinz Hildebrand

MSc

Get In Touch

Use the form below to contact us for more information.

XZELL

Pioneering work in liquid biopsies with a mission to make early cancer detection accessible for everybody today.

© 2017 XZELL INC

 

Find Us

XZELL HQ